EUVIMEDEUVIMED entdecken
Crossref

Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM)

Takafumi Kawata, Hiroshi Bando, Yoshinobu Kato, Yoshikane Kato, Setsuko Kanazawa, Etsuko Sueki, Hiroe Kanagawa, Atsuko Kawahito, Aya Aihara, Ayako Fujii

International Medicine · 2021 · 3 (2) · 65

DOI: 10.5455/im.59761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Medicine, 2021. Verfasst von Takafumi Kawata und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kawata, T., Bando, H., Kato, Y., Kato, Y., Kanazawa, S., Sueki, E., Kanagawa, H., Kawahito, A., Aihara, A., & Fujii, A. (2021). Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM). International Medicine, 3(2), 65. https://doi.org/10.5455/im.59761

Vancouver

Kawata T, Bando H, Kato Y, Kato Y, Kanazawa S, Sueki E, et al. Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM). International Medicine. 2021;3(2):65. doi:10.5455/im.59761

BibTeX
@article{Kawata2021,
  author = {Kawata, Takafumi and Bando, Hiroshi and Kato, Yoshinobu and Kato, Yoshikane and Kanazawa, Setsuko and Sueki, Etsuko and Kanagawa, Hiroe and Kawahito, Atsuko and Aihara, Aya and Fujii, Ayako},
  title = {Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM)},
  journal = {International Medicine},
  year = {2021},
  volume = {3},
  number = {2},
  pages = {65},
  doi = {10.5455/im.59761}
}
Kostenlos starten →